Literature DB >> 16557073

Squamous cell carcinoma developing on burn scar.

Ulker Gül1, Arzu Kiliç.   

Abstract

BACKGROUND: It is estimated that 2% of burn scars undergo malignant transformation. Squamous cell carcinoma (SCC) is the most common type of cancer that develops.
MATERIALS AND METHODS: We report a retrospective study, which consists of 510 patients who have 570 cases of tumors of SCC. We examined SCCs developing on burn scars retrospectively among 570 cases, and we found that 36 cases had SCC developing on burn scars. The records of those 36 cases were analyzed in terms of age, sex, latent period between burn and carcinoma, anatomic localization of the carcinoma, and the presence of metastases. These findings were compared with the SCC group that did not have burn history.
RESULTS: The number of SCC developing on burn scars among the 570 cases was 36 (6.31%), 15 of which were women (41.66%) and 21 were men (58.33%). The average age was 46.77 years. The average latent period between burn and the development of carcinoma was found to be 32.22 years. It should be mentioned that the burn scar carcinoma group was younger. In addition, burn scar carcinoma was more likely to localize on lower extremities and metastasize (P<0.001).
CONCLUSION: Having high aggressive features, the suspicion of development of SCC in burn scar should be kept in mind, so patients with burn scar must be followed periodically.

Entities:  

Mesh:

Year:  2006        PMID: 16557073     DOI: 10.1097/01.sap.0000200734.74303.d5

Source DB:  PubMed          Journal:  Ann Plast Surg        ISSN: 0148-7043            Impact factor:   1.539


  11 in total

1.  Malignant degeneration of scars in elderly people (Marjolin's ulcers).

Authors:  Piotr Brzezinski; Caius Solovan; Anca Chiriac
Journal:  Int Wound J       Date:  2015-01-20       Impact factor: 3.315

2.  A review of 31 cases of Marjolin's ulcer on scalp: Is it necessary to preventively remove the scar?

Authors:  Haitao Xiao; Ke Deng; Ruolin Liu; Zihang Chen; Yun Lin; Yuan Gao; Ying Cen; Xuewen Xu
Journal:  Int Wound J       Date:  2018-12-26       Impact factor: 3.315

Review 3.  Importance of high clinical suspicion in diagnosing a Marjolin's ulcer with an unusual presentation.

Authors:  Anna R Carlson; Vanessa Nomellini; Heather B Neuman
Journal:  Am Surg       Date:  2014-02       Impact factor: 0.688

4.  [Cutaneous malignancies in occupationally-induced scars].

Authors:  H C Broding; A Köllner; T Brüning; M Fartasch
Journal:  Hautarzt       Date:  2011-10       Impact factor: 0.751

5.  Histological changes after single high-dose irradiation for squamous cell carcinoma arising from a burn scar.

Authors:  Yayoi Kan; Hideomi Yamashita; Andores Le Pavoux; Tetsuo Ushiku; Kuni Ohtomo; Keiichi Nakagawa
Journal:  Med Oncol       Date:  2009-02-13       Impact factor: 3.064

6.  Clinical characteristics and therapeutic analysis of 51 patients with Marjolin's ulcers.

Authors:  Rui Shen; Jinming Zhang; Fenggang Zhang; Yongjun DU; Weiqiang Liang; Lusheng Xu; Xueliang DU; Ping Chen; Xiaodong Chen
Journal:  Exp Ther Med       Date:  2015-08-24       Impact factor: 2.447

7.  Marjolin's ulcer: clinical and pathologic features of 83 cases and review of literature.

Authors:  Mohammad Sadegh Fazeli; Amir Hosein Lebaschi; Morvarid Hajirostam; Mohammad Reza Keramati
Journal:  Med J Islam Repub Iran       Date:  2013-11

Review 8.  Successful surgical treatment for squamous cell carcinoma arising from hidradenitis suppurativa: A case report and literature review.

Authors:  Cheng Huang; Zhichao Lai; Mu He; Biyun Zhai; Liangrui Zhou; Xiao Long
Journal:  Medicine (Baltimore)       Date:  2017-01       Impact factor: 1.889

9.  Marjolin's ulcer: a preventable malignancy arising from scars.

Authors:  Nanze Yu; Xiao Long; Jorge R Lujan-Hernandez; Kazi Z Hassan; Ming Bai; Yang Wang; Xiaojun Wang; Ru Zhao
Journal:  World J Surg Oncol       Date:  2013-12-17       Impact factor: 2.754

10.  Comprehensive Analysis of Long Noncoding RNAs and Messenger RNAs Expression Profiles in Patients with Marjolin Ulcer.

Authors:  Zan Liu; Licheng Ren; Jing Tian; Ning Liu; Yanke Hu; Pihong Zhang
Journal:  Med Sci Monit       Date:  2018-11-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.